About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Provides Update on TPM Propofol Development Program

November 9, 2017

Click here to read more

Post navigation

Phosphagenics Mylan Arbitration Hearing Concluded

Phosphagenics Signs a Multinational License for TPM® in Personal Care Products

Related Posts

Phosphagenics Limited Annual General Meeting and Proxy Form

April 15, 2016

Phosphagenics Signs Development Agreement for TPM Oxymorphone Patch in Japan

August 22, 2017

Results for Phase I human clinical trial of CBD soft-gel product

December 8, 2021December 8, 2021

Recent Posts

Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.